Skip to main content

Table 2 Comparison between the mean of pre and post intervention values of biomarkers

From: Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study

Variable

Base line value Mean ± SD

Post intervention concentration value Mean ± SD

P.V.

95 % CI

Hb F (%)

6·68 ± 5.44

7·41 ± 5·38

.000 b

0·431–1·028

Hb S (%)

90 ± 5·15

89·24 ± 5·10

.000 b

0.455–1·043

Hb A2 (%)

3·3 ± 0·52

3·33 ± 0.48

0·901

0·064–0·072

Hemoglobin (g/dL)

7·28 ± 1·105

7·2638 ± 1·08

0·777

−0·142–0·188

MCV (fL)

85·2 ± 9.37

89·20 ± 12·33

·000 b

−2·312– − 6·058

PCV %

20·56 ± 3·15

21·57 ± 4·29

·026 a

0·124–1·902

MCH pg

30·32 ± 3·87

30·01 ± 4·11

0·270

−.2496–0·871

MCHC (g/dL)

35·2 ± 2·22

33·4 ± 2·29

·000 b

1·035–2·559

Reticulocyte count %

14·412 ± 4·27

16·27 ± 7·03

·185

−4·855–1·130

Platelets counts 103 /uL

448·27 ± 144·79

471·36 ± 169·41

·346

−71·94–25·76

WBCs 103 /uL

16·72 ± 16·3

13·54 ± 4·68

·195

−1·682–8·035

RBCs 106 /uL

2·37 ± 041

2·42 ± 0·45

·170

−0·1091–0·197

LDH U/L

717·23 ± 269·95

643·14 ± 244·5

·028 a

8·22–139·94

Erythropoietin IU/L

8·74 ± 2·96

8·782 ± 3·92

·926

−·944–·8617

  1. aDifference is significant at the 0.05 level (2-tailed)
  2. bDifference is significant at the 0.01 level (2-tailed)